Goodvalley A/S
01/02/2021
COMPANY ANNOUNCEMENT 1/2021
The Goodvalley board of directors has approved a facilities agreement consisting of two term loans in the aggregate amount of EUR 140,000,000 and two revolving credit facilities of up to EUR 10,000,000. The purpose of the facility is to refinance Goodvalley’s existing EUR 135,000,000 senior secured bond which matures on 24 May 2021.
Further information
CEO, Hans Henrik Pedersen
+ 45 76 52 20 00
investor@goodvalley.com
Goodvalley at a glance
Goodvalley is an international producer of high-quality pork products operating in Poland, Ukraine and Russia based on Danish production standards. The company is to a large extent self-sufficient and masters the whole production chain from field to fork, from growing crops for feed, breeding and slaughtering pigs including using the manure in biogas facilities to produce electricity and organic fertilizer for the fields. Goodvalley is certified as a carbon neutral company by German TÜV and operates according to the highest standards in terms of animal welfare, transparency in the production and sustainable production methods.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Kalmar Corporation30.10.2025 16:00:00 CET | Press release
Kalmar’s financial information in 2026
World Vapers’ Alliance30.10.2025 15:00:00 CET | Press release
Consumers Sound Alarm as WHO COP11 Threatens Harm Reduction
PLIDCO30.10.2025 15:00:00 CET | Press release
PLIDCO® Introduces Industry-Leading 10-Year Limited Warranty
Oma Säästöpankki Oyj30.10.2025 14:16:00 CET | Press release
Inside information: Oma Savings Bank Plc discontinues the IRB application process and does not seek IRB permit in the near future
Recor Medical30.10.2025 14:15:00 CET | Press release
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 months with Recor Medical’s Paradise Ultrasound Renal Denervation System
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
